1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Clone Competent Cell Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemically Competent Cells 1.2.3 Electrocompetent Cells 1.3 Market by Application 1.3.1 Global Clone Competent Cell Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Subcloning & Routine Cloning 1.3.3 Phage Display Library Construction 1.3.4 Toxic/Unstable Dna Cloning 1.3.5 High-Throughput Cloning 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Clone Competent Cell Market Perspective (2016-2027) 2.2 Clone Competent Cell Growth Trends by Regions 2.2.1 Clone Competent Cell Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Clone Competent Cell Historic Market Share by Regions (2016-2021) 2.2.3 Clone Competent Cell Forecasted Market Size by Regions (2022-2027) 2.3 Clone Competent Cell Industry Dynamic 2.3.1 Clone Competent Cell Market Trends 2.3.2 Clone Competent Cell Market Drivers 2.3.3 Clone Competent Cell Market Challenges 2.3.4 Clone Competent Cell Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Clone Competent Cell Players by Revenue 3.1.1 Global Top Clone Competent Cell Players by Revenue (2016-2021) 3.1.2 Global Clone Competent Cell Revenue Market Share by Players (2016-2021) 3.2 Global Clone Competent Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Clone Competent Cell Revenue 3.4 Global Clone Competent Cell Market Concentration Ratio 3.4.1 Global Clone Competent Cell Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Clone Competent Cell Revenue in 2020 3.5 Clone Competent Cell Key Players Head office and Area Served 3.6 Key Players Clone Competent Cell Product Solution and Service 3.7 Date of Enter into Clone Competent Cell Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Clone Competent Cell Breakdown Data by Type 4.1 Global Clone Competent Cell Historic Market Size by Type (2016-2021) 4.2 Global Clone Competent Cell Forecasted Market Size by Type (2022-2027) 5 Clone Competent Cell Breakdown Data by Application 5.1 Global Clone Competent Cell Historic Market Size by Application (2016-2021) 5.2 Global Clone Competent Cell Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Clone Competent Cell Market Size (2016-2027) 6.2 North America Clone Competent Cell Market Size by Type 6.2.1 North America Clone Competent Cell Market Size by Type (2016-2021) 6.2.2 North America Clone Competent Cell Market Size by Type (2022-2027) 6.2.3 North America Clone Competent Cell Market Size by Type (2016-2027) 6.3 North America Clone Competent Cell Market Size by Application 6.3.1 North America Clone Competent Cell Market Size by Application (2016-2021) 6.3.2 North America Clone Competent Cell Market Size by Application (2022-2027) 6.3.3 North America Clone Competent Cell Market Size by Application (2016-2027) 6.4 North America Clone Competent Cell Market Size by Country 6.4.1 North America Clone Competent Cell Market Size by Country (2016-2021) 6.4.2 North America Clone Competent Cell Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Clone Competent Cell Market Size (2016-2027) 7.2 Europe Clone Competent Cell Market Size by Type 7.2.1 Europe Clone Competent Cell Market Size by Type (2016-2021) 7.2.2 Europe Clone Competent Cell Market Size by Type (2022-2027) 7.2.3 Europe Clone Competent Cell Market Size by Type (2016-2027) 7.3 Europe Clone Competent Cell Market Size by Application 7.3.1 Europe Clone Competent Cell Market Size by Application (2016-2021) 7.3.2 Europe Clone Competent Cell Market Size by Application (2022-2027) 7.3.3 Europe Clone Competent Cell Market Size by Application (2016-2027) 7.4 Europe Clone Competent Cell Market Size by Country 7.4.1 Europe Clone Competent Cell Market Size by Country (2016-2021) 7.4.2 Europe Clone Competent Cell Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Clone Competent Cell Market Size (2016-2027) 8.2 Asia-Pacific Clone Competent Cell Market Size by Type 8.2.1 Asia-Pacific Clone Competent Cell Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Clone Competent Cell Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Clone Competent Cell Market Size by Type (2016-2027) 8.3 Asia-Pacific Clone Competent Cell Market Size by Application 8.3.1 Asia-Pacific Clone Competent Cell Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Clone Competent Cell Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Clone Competent Cell Market Size by Application (2016-2027) 8.4 Asia-Pacific Clone Competent Cell Market Size by Region 8.4.1 Asia-Pacific Clone Competent Cell Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Clone Competent Cell Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Clone Competent Cell Market Size (2016-2027) 9.2 Latin America Clone Competent Cell Market Size by Type 9.2.1 Latin America Clone Competent Cell Market Size by Type (2016-2021) 9.2.2 Latin America Clone Competent Cell Market Size by Type (2022-2027) 9.2.3 Latin America Clone Competent Cell Market Size by Type (2016-2027) 9.3 Latin America Clone Competent Cell Market Size by Application 9.3.1 Latin America Clone Competent Cell Market Size by Application (2016-2021) 9.3.2 Latin America Clone Competent Cell Market Size by Application (2022-2027) 9.3.3 Latin America Clone Competent Cell Market Size by Application (2016-2027) 9.4 Latin America Clone Competent Cell Market Size by Country 9.4.1 Latin America Clone Competent Cell Market Size by Country (2016-2021) 9.4.2 Latin America Clone Competent Cell Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Clone Competent Cell Market Size (2016-2027) 10.2 Middle East & Africa Clone Competent Cell Market Size by Type 10.2.1 Middle East & Africa Clone Competent Cell Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Clone Competent Cell Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Clone Competent Cell Market Size by Type (2016-2027) 10.3 Middle East & Africa Clone Competent Cell Market Size by Application 10.3.1 Middle East & Africa Clone Competent Cell Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Clone Competent Cell Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Clone Competent Cell Market Size by Application (2016-2027) 10.4 Middle East & Africa Clone Competent Cell Market Size by Country 10.4.1 Middle East & Africa Clone Competent Cell Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Clone Competent Cell Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck KGaA 11.1.1 Merck KGaA Company Details 11.1.2 Merck KGaA Business Overview 11.1.3 Merck KGaA Clone Competent Cell Introduction 11.1.4 Merck KGaA Revenue in Clone Competent Cell Business (2016-2021) 11.1.5 Merck KGaA Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Clone Competent Cell Introduction 11.2.4 Thermo Fisher Scientific Revenue in Clone Competent Cell Business (2016-2021) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 Agilent Technologies 11.3.1 Agilent Technologies Company Details 11.3.2 Agilent Technologies Business Overview 11.3.3 Agilent Technologies Clone Competent Cell Introduction 11.3.4 Agilent Technologies Revenue in Clone Competent Cell Business (2016-2021) 11.3.5 Agilent Technologies Recent Development 11.4 Takara Bio 11.4.1 Takara Bio Company Details 11.4.2 Takara Bio Business Overview 11.4.3 Takara Bio Clone Competent Cell Introduction 11.4.4 Takara Bio Revenue in Clone Competent Cell Business (2016-2021) 11.4.5 Takara Bio Recent Development 11.5 Promega Corporation 11.5.1 Promega Corporation Company Details 11.5.2 Promega Corporation Business Overview 11.5.3 Promega Corporation Clone Competent Cell Introduction 11.5.4 Promega Corporation Revenue in Clone Competent Cell Business (2016-2021) 11.5.5 Promega Corporation Recent Development 11.6 Beijing TransGen Biotech 11.6.1 Beijing TransGen Biotech Company Details 11.6.2 Beijing TransGen Biotech Business Overview 11.6.3 Beijing TransGen Biotech Clone Competent Cell Introduction 11.6.4 Beijing TransGen Biotech Revenue in Clone Competent Cell Business (2016-2021) 11.6.5 Beijing TransGen Biotech Recent Development 11.7 GeneScript Corporation 11.7.1 GeneScript Corporation Company Details 11.7.2 GeneScript Corporation Business Overview 11.7.3 GeneScript Corporation Clone Competent Cell Introduction 11.7.4 GeneScript Corporation Revenue in Clone Competent Cell Business (2016-2021) 11.7.5 GeneScript Corporation Recent Development 11.8 Yeastern Biotech 11.8.1 Yeastern Biotech Company Details 11.8.2 Yeastern Biotech Business Overview 11.8.3 Yeastern Biotech Clone Competent Cell Introduction 11.8.4 Yeastern Biotech Revenue in Clone Competent Cell Business (2016-2021) 11.8.5 Yeastern Biotech Recent Development 11.9 New England Biolabs 11.9.1 New England Biolabs Company Details 11.9.2 New England Biolabs Business Overview 11.9.3 New England Biolabs Clone Competent Cell Introduction 11.9.4 New England Biolabs Revenue in Clone Competent Cell Business (2016-2021) 11.9.5 New England Biolabs Recent Development 11.10 QIAGEN N.V. 11.10.1 QIAGEN N.V. Company Details 11.10.2 QIAGEN N.V. Business Overview 11.10.3 QIAGEN N.V. Clone Competent Cell Introduction 11.10.4 QIAGEN N.V. Revenue in Clone Competent Cell Business (2016-2021) 11.10.5 QIAGEN N.V. Recent Development 11.11 OriGene Technologies 11.11.1 OriGene Technologies Company Details 11.11.2 OriGene Technologies Business Overview 11.11.3 OriGene Technologies Clone Competent Cell Introduction 11.11.4 OriGene Technologies Revenue in Clone Competent Cell Business (2016-2021) 11.11.5 OriGene Technologies Recent Development 11.12 Lucigen 11.12.1 Lucigen Company Details 11.12.2 Lucigen Business Overview 11.12.3 Lucigen Clone Competent Cell Introduction 11.12.4 Lucigen Revenue in Clone Competent Cell Business (2016-2021) 11.12.5 Lucigen Recent Development 11.13 Zymo Research 11.13.1 Zymo Research Company Details 11.13.2 Zymo Research Business Overview 11.13.3 Zymo Research Clone Competent Cell Introduction 11.13.4 Zymo Research Revenue in Clone Competent Cell Business (2016-2021) 11.13.5 Zymo Research Recent Development 11.14 Bio-Rad Laboratories 11.14.1 Bio-Rad Laboratories Company Details 11.14.2 Bio-Rad Laboratories Business Overview 11.14.3 Bio-Rad Laboratories Clone Competent Cell Introduction 11.14.4 Bio-Rad Laboratories Revenue in Clone Competent Cell Business (2016-2021) 11.14.5 Bio-Rad Laboratories Recent Development 11.15 Bioline 11.15.1 Bioline Company Details 11.15.2 Bioline Business Overview 11.15.3 Bioline Clone Competent Cell Introduction 11.15.4 Bioline Revenue in Clone Competent Cell Business (2016-2021) 11.15.5 Bioline Recent Development 11.16 Delphi Genetics 11.16.1 Delphi Genetics Company Details 11.16.2 Delphi Genetics Business Overview 11.16.3 Delphi Genetics Clone Competent Cell Introduction 11.16.4 Delphi Genetics Revenue in Clone Competent Cell Business (2016-2021) 11.16.5 Delphi Genetics Recent Development 11.17 IBA GmBH 11.17.1 IBA GmBH Company Details 11.17.2 IBA GmBH Business Overview 11.17.3 IBA GmBH Clone Competent Cell Introduction 11.17.4 IBA GmBH Revenue in Clone Competent Cell Business (2016-2021) 11.17.5 IBA GmBH Recent Development 11.18 Cell Applications 11.18.1 Cell Applications Company Details 11.18.2 Cell Applications Business Overview 11.18.3 Cell Applications Clone Competent Cell Introduction 11.18.4 Cell Applications Revenue in Clone Competent Cell Business (2016-2021) 11.18.5 Cell Applications Recent Development 11.19 BioDynamics Laboratory 11.19.1 BioDynamics Laboratory Company Details 11.19.2 BioDynamics Laboratory Business Overview 11.19.3 BioDynamics Laboratory Clone Competent Cell Introduction 11.19.4 BioDynamics Laboratory Revenue in Clone Competent Cell Business (2016-2021) 11.19.5 BioDynamics Laboratory Recent Development 11.20 Scarab Genomics 11.20.1 Scarab Genomics Company Details 11.20.2 Scarab Genomics Business Overview 11.20.3 Scarab Genomics Clone Competent Cell Introduction 11.20.4 Scarab Genomics Revenue in Clone Competent Cell Business (2016-2021) 11.20.5 Scarab Genomics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Clone Competent Cell Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemically Competent Cells Table 3. Key Players of Electrocompetent Cells Table 4. Global Clone Competent Cell Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Clone Competent Cell Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Clone Competent Cell Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Clone Competent Cell Market Share by Regions (2016-2021) Table 8. Global Clone Competent Cell Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Clone Competent Cell Market Share by Regions (2022-2027) Table 10. Clone Competent Cell Market Trends Table 11. Clone Competent Cell Market Drivers Table 12. Clone Competent Cell Market Challenges Table 13. Clone Competent Cell Market Restraints Table 14. Global Clone Competent Cell Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Clone Competent Cell Market Share by Players (2016-2021) Table 16. Global Top Clone Competent Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clone Competent Cell as of 2020) Table 17. Ranking of Global Top Clone Competent Cell Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Clone Competent Cell Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Clone Competent Cell Product Solution and Service Table 21. Date of Enter into Clone Competent Cell Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Clone Competent Cell Market Size by Type (2016-2021) (US$ Million) Table 24. Global Clone Competent Cell Revenue Market Share by Type (2016-2021) Table 25. Global Clone Competent Cell Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Clone Competent Cell Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Clone Competent Cell Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Clone Competent Cell Revenue Market Share by Application (2016-2021) Table 29. Global Clone Competent Cell Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Clone Competent Cell Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Clone Competent Cell Market Size by Type (2016-2021) (US$ Million) Table 32. North America Clone Competent Cell Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Clone Competent Cell Market Size by Application (2016-2021) (US$ Million) Table 34. North America Clone Competent Cell Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Clone Competent Cell Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Clone Competent Cell Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Clone Competent Cell Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Clone Competent Cell Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Clone Competent Cell Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Clone Competent Cell Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Clone Competent Cell Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Clone Competent Cell Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Clone Competent Cell Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Clone Competent Cell Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Clone Competent Cell Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Clone Competent Cell Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Clone Competent Cell Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Clone Competent Cell Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Clone Competent Cell Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Clone Competent Cell Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Clone Competent Cell Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Clone Competent Cell Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Clone Competent Cell Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Clone Competent Cell Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Clone Competent Cell Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Clone Competent Cell Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Clone Competent Cell Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Clone Competent Cell Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Clone Competent Cell Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Clone Competent Cell Market Size by Country (2022-2027) & (US$ Million) Table 61. Merck KGaA Company Details Table 62. Merck KGaA Business Overview Table 63. Merck KGaA Clone Competent Cell Product Table 64. Merck KGaA Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 65. Merck KGaA Recent Development Table 66. Thermo Fisher Scientific Company Details Table 67. Thermo Fisher Scientific Business Overview Table 68. Thermo Fisher Scientific Clone Competent Cell Product Table 69. Thermo Fisher Scientific Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 70. Thermo Fisher Scientific Recent Development Table 71. Agilent Technologies Company Details Table 72. Agilent Technologies Business Overview Table 73. Agilent Technologies Clone Competent Cell Product Table 74. Agilent Technologies Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 75. Agilent Technologies Recent Development Table 76. Takara Bio Company Details Table 77. Takara Bio Business Overview Table 78. Takara Bio Clone Competent Cell Product Table 79. Takara Bio Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 80. Takara Bio Recent Development Table 81. Promega Corporation Company Details Table 82. Promega Corporation Business Overview Table 83. Promega Corporation Clone Competent Cell Product Table 84. Promega Corporation Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 85. Promega Corporation Recent Development Table 86. Beijing TransGen Biotech Company Details Table 87. Beijing TransGen Biotech Business Overview Table 88. Beijing TransGen Biotech Clone Competent Cell Product Table 89. Beijing TransGen Biotech Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 90. Beijing TransGen Biotech Recent Development Table 91. GeneScript Corporation Company Details Table 92. GeneScript Corporation Business Overview Table 93. GeneScript Corporation Clone Competent Cell Product Table 94. GeneScript Corporation Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 95. GeneScript Corporation Recent Development Table 96. Yeastern Biotech Company Details Table 97. Yeastern Biotech Business Overview Table 98. Yeastern Biotech Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 99. Yeastern Biotech Recent Development Table 100. New England Biolabs Company Details Table 101. New England Biolabs Business Overview Table 102. New England Biolabs Clone Competent Cell Product Table 103. New England Biolabs Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 104. New England Biolabs Recent Development Table 105. QIAGEN N.V. Company Details Table 106. QIAGEN N.V. Business Overview Table 107. QIAGEN N.V. Clone Competent Cell Product Table 108. QIAGEN N.V. Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 109. QIAGEN N.V. Recent Development Table 110. OriGene Technologies Company Details Table 111. OriGene Technologies Business Overview Table 112. OriGene Technologies Clone Competent Cell Product Table 113. OriGene Technologies Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 114. OriGene Technologies Recent Development Table 115. Lucigen Company Details Table 116. Lucigen Business Overview Table 117. Lucigen Clone Competent Cell Product Table 118. Lucigen Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 119. Lucigen Recent Development Table 120. Zymo Research Company Details Table 121. Zymo Research Business Overview Table 122. Zymo Research Clone Competent Cell Product Table 123. Zymo Research Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 124. Zymo Research Recent Development Table 125. Bio-Rad Laboratories Company Details Table 126. Bio-Rad Laboratories Business Overview Table 127. Bio-Rad Laboratories Clone Competent Cell Product Table 128. Bio-Rad Laboratories Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 129. Bio-Rad Laboratories Recent Development Table 130. Bioline Company Details Table 131. Bioline Business Overview Table 132. Bioline Clone Competent Cell Product Table 133. Bioline Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 134. Bioline Recent Development Table 135. Delphi Genetics Company Details Table 136. Delphi Genetics Business Overview Table 137. Delphi Genetics Clone Competent Cell Product Table 138. Delphi Genetics Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 139. Delphi Genetics Recent Development Table 140. IBA GmBH Company Details Table 141. IBA GmBH Business Overview Table 142. IBA GmBH Clone Competent Cell Product Table 143. IBA GmBH Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 144. IBA GmBH Recent Development Table 145. Cell Applications Company Details Table 146. Cell Applications Business Overview Table 147. Cell Applications Clone Competent Cell Product Table 148. Cell Applications Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 149. Cell Applications Recent Development Table 150. BioDynamics Laboratory Company Details Table 151. BioDynamics Laboratory Business Overview Table 152. BioDynamics Laboratory Clone Competent Cell Product Table 153. BioDynamics Laboratory Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 154. BioDynamics Laboratory Recent Development Table 155. Scarab Genomics Company Details Table 156. Scarab Genomics Business Overview Table 157. Scarab Genomics Clone Competent Cell Product Table 158. Scarab Genomics Revenue in Clone Competent Cell Business (2016-2021) & (US$ Million) Table 159. Scarab Genomics Recent Development Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Global Clone Competent Cell Market Share by Type: 2020 VS 2027 Figure 2. Chemically Competent Cells Features Figure 3. Electrocompetent Cells Features Figure 4. Global Clone Competent Cell Market Share by Application: 2020 VS 2027 Figure 5. Subcloning & Routine Cloning Case Studies Figure 6. Phage Display Library Construction Case Studies Figure 7. Toxic/Unstable Dna Cloning Case Studies Figure 8. High-Throughput Cloning Case Studies Figure 9. Clone Competent Cell Report Years Considered Figure 10. Global Clone Competent Cell Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Clone Competent Cell Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Clone Competent Cell Market Share by Regions: 2020 VS 2027 Figure 13. Global Clone Competent Cell Market Share by Regions (2022-2027) Figure 14. Global Clone Competent Cell Market Share by Players in 2020 Figure 15. Global Top Clone Competent Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clone Competent Cell as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Clone Competent Cell Revenue in 2020 Figure 17. Global Clone Competent Cell Revenue Market Share by Type (2016-2021) Figure 18. Global Clone Competent Cell Revenue Market Share by Type (2022-2027) Figure 19. North America Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Clone Competent Cell Market Share by Type (2016-2027) Figure 21. North America Clone Competent Cell Market Share by Application (2016-2027) Figure 22. North America Clone Competent Cell Market Share by Country (2016-2027) Figure 23. United States Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Clone Competent Cell Market Share by Type (2016-2027) Figure 27. Europe Clone Competent Cell Market Share by Application (2016-2027) Figure 28. Europe Clone Competent Cell Market Share by Country (2016-2027) Figure 29. Germany Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Clone Competent Cell Market Share by Type (2016-2027) Figure 37. Asia-Pacific Clone Competent Cell Market Share by Application (2016-2027) Figure 38. Asia-Pacific Clone Competent Cell Market Share by Region (2016-2027) Figure 39. China Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Clone Competent Cell Market Share by Type (2016-2027) Figure 47. Latin America Clone Competent Cell Market Share by Application (2016-2027) Figure 48. Latin America Clone Competent Cell Market Share by Country (2016-2027) Figure 49. Mexico Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Clone Competent Cell Market Share by Type (2016-2027) Figure 53. Middle East & Africa Clone Competent Cell Market Share by Application (2016-2027) Figure 54. Middle East & Africa Clone Competent Cell Market Share by Country (2016-2027) Figure 55. Turkey Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Clone Competent Cell Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Merck KGaA Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 60. Agilent Technologies Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 61. Takara Bio Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 62. Promega Corporation Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 63. Beijing TransGen Biotech Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 64. GeneScript Corporation Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 65. Yeastern Biotech Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 66. New England Biolabs Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 67. QIAGEN N.V. Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 68. OriGene Technologies Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 69. Lucigen Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 70. Zymo Research Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 72. Bioline Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 73. Delphi Genetics Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 74. IBA GmBH Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 75. Cell Applications Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 76. BioDynamics Laboratory Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 77. Scarab Genomics Revenue Growth Rate in Clone Competent Cell Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Merck KGaA Thermo Fisher Scientific Agilent Technologies Takara Bio Promega Corporation Beijing TransGen Biotech GeneScript Corporation Yeastern Biotech New England Biolabs QIAGEN N.V. OriGene Technologies Lucigen Zymo Research Bio-Rad Laboratories Bioline Delphi Genetics IBA GmBH Cell Applications BioDynamics Laboratory Scarab Genomics